Crosstalk Between circRNA and Tumor Microenvironment of Hepatocellular Carcinoma: Mechanism, Function and Applications
Chenxi Xie,Xiaopei Hao,Hao Yuan,Chongyu Wang,Razinah Sharif,Haibo Yu
DOI: https://doi.org/10.2147/ott.s437536
IF: 4
2024-01-23
OncoTargets and Therapy
Abstract:Chenxi Xie, 1, &ast Xiaopei Hao, 2, &ast Hao Yuan, 1 Chongyu Wang, 3 Razinah Sharif, 4, 5 Haibo Yu 1 1 Hepatobiliary Center, Department of Hepatobiliary Surgery, People's Hospital of Zhengzhou University, Zhengzhou, People's Republic of China; 2 The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, People's Republic of China; 3 The First Clinical Medical College of Xuzhou Medical University, Xuzhou, People's Republic of China; 4 Center for Healthy Ageing & Wellness, Faculty of Health Sciences, University Kebangsaan Malaysia, Kuala Lumpur, 50300, Malaysia; 5 Biocompatibility Laboratory, Centre for Research and Instrumentation, University Kebangsaan Malaysia, UKM, Bangi, Selangor Darul Ehsan, 43600, Malaysia &astThese authors contributed equally to this work Correspondence: Haibo Yu, The People's Hospital of Zhengzhou University, 7 Weiwu Road, Jinshui District, Zhengzhou, 450003, People's Republic of China, Tel +86- 371 – 65580213, Email Razinah Sharif, Center for Healthy Ageing & Wellness, Faculty of Health Sciences, University Kebangsaan Malaysia, Jalan Raja Muda Abdul Aziz, Kuala Lumpur, 50300, Malaysia, Tel +60- 3 – 60193009360, Email Hepatocellular carcinoma (HCC) is one of the most common aggressive tumors in the world. Despite the availability of various treatments, its prognosis remains poor due to the lack of specific diagnostic indicators and the high heterogeneity of HCC cases. CircRNAs are noncoding RNAs with stable and highly specific expression. Extensive research evidence suggests that circRNAs mediate the pathogenesis and progression of HCC through acting as miRNA sponges, protein modulators, and translation templates. Tumor microenvironment (TME) has become a hotspot of immune-related research in recent years due to its effects on metabolism, secretion and immunity of HCC. Accordingly, understanding the role played by circRNAs in TME is important for the study of HCC. This review will discuss the crosstalk between circRNAs and TME in HCC. In addition, we will discuss the current deficiencies and controversies in research on circRNAs and predict future research directions. Keywords: CircRNAs, hepatocellular carcinoma, characteristics, tumor microenvironment, biomarker Hepatocellular carcinoma (HCC) is the main subtype of primary liver cancer, accounting for approximately 80% of primary liver cancer cases. Globally, HCC ranks sixth in cancer incidence rate and second in cancer mortality. The main causes of HCC are hepatitis B (HBV) and hepatitis C (HCV) infections, liver cirrhosis, and alcohol consumption. 1 In addition, diabetes and non-alcoholic fatty liver are also closely related to the development of HCC. 2 Early HCC can be treated through surgical resection, radiation therapy, or liver transplantation. However, most cases miss the opportunity for surgery because of not being diagnosed HCC until the cancer progresses to advanced stage, which could be attributed to the lack of valid and high-performance biomarkers. Nowadays, in addition to Alpha-fetoprotein (AFP) as the common biomarker, there are other potential biomarkers for early detection of HCC, such as Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II) and Glypican-3 (GPC3). However, the sensitivity and specificity of these biomarkers are often insufficient to aid in early HCC diagnosis. 3,4 Although the use of new drugs significantly improves the survival and prognosis of patients with advanced HCC, this method also faces the challenge of cancer cells gaining resistance. After surgery, approximately 25% of patients relapse within five years with poor prognosis. 5,6 High heterogeneity and lack of early diagnostic markers are the main challenges for the treatment of HCC. 2 Therefore, elucidating the pathogenesis and progression of HCC is crucial for developing new remedy. CircRNA is a type of transcript that lacks coding ability and is widely expressed in viruses, plants, animals, and other organisms. 7 In 1976, Sanger used electron microscopy to first discover circular RNA in virus-like organisms and confirmed its existence. Subsequently, circRNA was observed to exist in the cytoplasm of eukaryotic cells. 8 In 1993, it was discovered that the mouse Sry gene could transcribe circRNAs. 9 At this point, circRNA is still considered a non- functional byproduct of transcription. 10 In 2012, with the help of high-throughput sequencing, a large number of circRNAs were identified. Meanwhile, it was found that circRNA has specificity and conservation, far lower than homologous linear transcripts. In 2013, research on -Abstract Truncated-
oncology,biotechnology & applied microbiology